Elpiscience and Astellas enter into research collaboration and license agreement
Elpiscience Biopharma, Ltd. and Astellas Pharma Inc. recently announced a research collaboration and license agreement for novel bi-specific macrophage engagers, ES019 and another program. The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up to two additional programs to be included in the […]
